Home
BCTX
BCTX News

Latest BriaCell Therapeutics Corp. (BCTX) News on September 4, 2025

BriaCell Selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

GlobeNewswire

23 days ago

BriaCell Selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Here's Why We're A Bit Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation

Simply Wall St.

2 months ago

Here's Why We're A Bit Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation

MT Newswires

2 months ago

BriaCell Up in U.S. Pre-market, as Data Safety Board Review Recommends Phase 3 Study Continues

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire

2 months ago

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

GlobeNewswire

3 months ago

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

MT Newswires

3 months ago

BriaCell Reports "Robust" Overall Survival and Clinical Benefit Data at ASCO 2025

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025

GlobeNewswire

3 months ago

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

GOBankingRates

3 months ago

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

3 International Vacations That Are Cheaper Than an iPhone

GOBankingRates

3 months ago

3 International Vacations That Are Cheaper Than an iPhone

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

GOBankingRates

3 months ago

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

This week in Trumponomics: Too bad TACO isn’t true

Yahoo Finance

3 months ago

This week in Trumponomics: Too bad TACO isn’t true

Starmer says Farage would spook the City and give us Truss 2 – he could be right

The Guardian

3 months ago

Starmer says Farage would spook the City and give us Truss 2 – he could be right

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Yahoo Finance Video

3 months ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Benzinga

3 months ago

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Reuters

3 months ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

MT Newswires

3 months ago

BriaCell Down More Than 2% Even As Says Bria-OTS Phase 1/2 Study Clears Safety Evaluation; First Patient Dosed

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor

GlobeNewswire

3 months ago

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor

MT Newswires

3 months ago

BriaCell to Showcase Survival and Clinical Benefit Data at ASCO Meeting Next Week

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025

GlobeNewswire

3 months ago

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025

BriaCell CEO Letter to Shareholders

GlobeNewswire

4 months ago

BriaCell CEO Letter to Shareholders

GlobeNewswire

4 months ago

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

GlobeNewswire

4 months ago

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

MT Newswires

4 months ago

BriaCell Therapeutics Lower, Says Presenting Positive Phase 2 Data at AACR

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

GlobeNewswire

4 months ago

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

MT Newswires

4 months ago

BriaCell Therapeutics to Raise $13.8 Million in Public Offering; Shares Fall

MT Newswires

4 months ago

BriaCell Therapeutics Down 17% In US Premarket As Prices US$13.8 Million Public Offering

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

GlobeNewswire

4 months ago

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

MT Newswires

4 months ago

Update: BriaCell Jumps More Than 30% As Reports Complete Lung Metastasis Resolution in Patient

MT Newswires

4 months ago

BriaCell Jumps 41% in U.S. Pre-market Trading, Reports Complete Lung Metastasis Resolution in Patient

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

GlobeNewswire

4 months ago

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

GlobeNewswire

4 months ago

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

GlobeNewswire

4 months ago

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

MT Newswires

5 months ago

BriaCell Therapeutics Up 7% as It Reports Latest Survival Data From Phase 2 Breast Cancer Study

MT Newswires

5 months ago

Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday

MT Newswires

5 months ago

BriaCell Says Breast Cancer Therapy Shows Positive Survival Data; Shares Rise

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

GlobeNewswire

5 months ago

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

MT Newswires

5 months ago

BriaCell Subsidiary Develops Antibodies to Anti-Cancer Target B7-H3

BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3

GlobeNewswire

5 months ago

BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference

GlobeNewswire

5 months ago

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference

MT Newswires

5 months ago

BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire

5 months ago

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer

BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Zacks

7 months ago

BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

GlobeNewswire

7 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

BriaCell Therapeutics Announces Closing of Public Offering

GlobeNewswire

7 months ago

BriaCell Therapeutics Announces Closing of Public Offering

BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

7 months ago

BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?

MT Newswires

7 months ago

Top Premarket Decliners

BriaCell Therapeutics Announces Pricing of Public Offering

GlobeNewswire

7 months ago

BriaCell Therapeutics Announces Pricing of Public Offering

BriaCell Therapeutics Announces Proposed Public Offering of Common Shares

GlobeNewswire

7 months ago

BriaCell Therapeutics Announces Proposed Public Offering of Common Shares

BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™

GlobeNewswire

7 months ago

BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™

MT Newswires

7 months ago

BriaCell Therapeutics Completes 15:1 Share Consolidation

BriaCell Announces Completion of 15:1 Share Consolidation

GlobeNewswire

7 months ago

BriaCell Announces Completion of 15:1 Share Consolidation

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025

GlobeNewswire

8 months ago

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025

BriaCell Announces Proposed Effective Date of Share Consolidation

GlobeNewswire

8 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m

Simply Wall St.

9 months ago

Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m

BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

GlobeNewswire

9 months ago

BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

GlobeNewswire

9 months ago

BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

MT Newswires

9 months ago

BriaCell Therapeutics Raises $5.55 Million in an Underwritten Offering of Share Units

BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering

GlobeNewswire

9 months ago

BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

GlobeNewswire

9 months ago

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

GlobeNewswire

9 months ago

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

MT Newswires

9 months ago

BriaCell Therapeutics Plans Public Offering; Shares Plunge After Hours

BriaCell Therapeutics Announces Proposed Public Offering

GlobeNewswire

9 months ago

BriaCell Therapeutics Announces Proposed Public Offering

BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

GlobeNewswire

9 months ago

BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire

9 months ago

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

GlobeNewswire

9 months ago

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

BriaCell Provides Update to its Board of Directors

GlobeNewswire

9 months ago

BriaCell Provides Update to its Board of Directors

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

GlobeNewswire

9 months ago

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

GlobeNewswire

10 months ago

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

GlobeNewswire

10 months ago

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

MT Newswires

10 months ago

BriaCell Higher as it Reports "Standard-Beating" Survival Data From Phase 2 Study

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

GlobeNewswire

10 months ago

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

MT Newswires

a year ago

BriaCell to Complete Patient Enrollment for Phase 3 Breast Cancer Study by Mid-2025; Shares Rise

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

GlobeNewswire

a year ago

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

MT Newswires

a year ago

BriaCell Therapeutics Closes Offering of 5.13 Million Shares, Warrants

BriaCell Therapeutics Announces Closing of $5 Million Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces Closing of $5 Million Offering

MT Newswires

a year ago

BriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering

MT Newswires

a year ago

BriaCell Therapeutics Down 41% as it Announces US$5-Million Share-Unit Offering

BriaCell Therapeutics Announces $5 Million Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces $5 Million Offering

MT Newswires

a year ago

BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

GlobeNewswire

a year ago

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

Zacks

a year ago

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

MT Newswires

a year ago

BriaCell Says FDA Greenlit Expanded Access Policy for Metastatic Breast Cancer Patients

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

GlobeNewswire

a year ago

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

MT Newswires

a year ago

BriaCell Therapeutics Closes $8.5 Million Offering

BriaCell Therapeutics Announces Closing of $8.5 Million Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces Closing of $8.5 Million Offering

MT Newswires

a year ago

BriaCell Therapeutics Announces US$8.5 Million Share Offering

MT Newswires

a year ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

MT Newswires

a year ago

BriaCell Therapeutics Prices $8.5 Million Offering

BriaCell Therapeutics Announces $8.5 Million Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces $8.5 Million Offering

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday

Benzinga

a year ago

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday

MT Newswires

a year ago

Update: BriaCell Shares Surge After Reporting Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study

MT Newswires

a year ago

Sector Update: Health Care Stocks Narrowly Mixed Premarket Wednesday

MT Newswires

a year ago

BriaCell Reports Longer Overall Survival Rate in Phase 2 Breast Cancer Study

MT Newswires

a year ago

BriaCell Reports Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study - Shares Soar Premarket

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer

GlobeNewswire

a year ago

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer

MT Newswires

a year ago

BriaCell Receives Positive Feedback From FDA Meeting Over Potential Prostate Cancer Drug

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer

GlobeNewswire

a year ago

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer

BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire

a year ago

BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer

GlobeNewswire

a year ago

BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer

BriaCell Presents Clinical Efficacy Data at ASCO 2024

GlobeNewswire

a year ago

BriaCell Presents Clinical Efficacy Data at ASCO 2024

Share on Social Networks: